Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13


Mindfulness-Based Strategies: A Cost-Effective Stress Reduction Method for Parents in the NICU.

Joseph R, Wellings A, Votta G.

Neonatal Netw. 2019 May 1;38(3):135-143. doi: 10.1891/0730-0832.38.3.135. Epub 2019 May 20.


Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis.

Ricciardiello F, Votta G, Palorini R, Raccagni I, Brunelli L, Paiotta A, Tinelli F, D'Orazio G, Valtorta S, De Gioia L, Pastorelli R, Moresco RM, La Ferla B, Chiaradonna F.

Cell Death Dis. 2018 Mar 7;9(3):377. doi: 10.1038/s41419-018-0405-4.


Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis.

Palorini R, Votta G, Pirola Y, De Vitto H, De Palma S, Airoldi C, Vasso M, Ricciardiello F, Lombardi PP, Cirulli C, Rizzi R, Nicotra F, Hiller K, Gelfi C, Alberghina L, Chiaradonna F.

PLoS Genet. 2016 Mar 15;12(3):e1005931. doi: 10.1371/journal.pgen.1005931. eCollection 2016 Mar.


Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer.

De Rosa V, Iommelli F, Monti M, Fonti R, Votta G, Stoppelli MP, Del Vecchio S.

Clin Cancer Res. 2015 Nov 15;21(22):5110-20. doi: 10.1158/1078-0432.CCR-15-0375. Epub 2015 Jul 27.


Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence.

Bifulco K, Votta G, Ingangi V, Di Carluccio G, Rea D, Losito S, Montuori N, Ragno P, Stoppelli MP, Arra C, Carriero MV.

Oncotarget. 2014 Jun 30;5(12):4154-69.


New Insights into the Connection Between Histone Deacetylases, Cell Metabolism, and Cancer.

Chiaradonna F, Cirulli C, Palorini R, Votta G, Alberghina L.

Antioxid Redox Signal. 2015 Jul 1;23(1):30-50. doi: 10.1089/ars.2014.5854. Epub 2014 Mar 6. Review.


Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS.

Palorini R, Votta G, Balestrieri C, Monestiroli A, Olivieri S, Vento R, Chiaradonna F.

J Cell Biochem. 2014 Feb;115(2):368-79. doi: 10.1002/jcb.24671.


Opposite modulation of cell migration by distinct subregions of urokinase connecting peptide.

Franco P, Carotenuto A, Marcozzi C, Votta G, Sarno C, Iaccarino I, Brancaccio D, De Vincenzo A, Novellino E, Grieco P, Stoppelli MP.

Chembiochem. 2013 May 10;14(7):882-9. doi: 10.1002/cbic.201200774. Epub 2013 Mar 20.


Analysis of secretome changes uncovers an autocrine/paracrine component in the modulation of cell proliferation and motility by c-Myc.

Pocsfalvi G, Votta G, De Vincenzo A, Fiume I, Raj DA, Marra G, Stoppelli MP, Iaccarino I.

J Proteome Res. 2011 Dec 2;10(12):5326-37. doi: 10.1021/pr200584y. Epub 2011 Nov 8.


Regulation of cell migration and invasion by specific modules of uPA: mechanistic insights and specific inhibitors.

Carriero MV, Franco P, Votta G, Longanesi-Cattani I, Vento MT, Masucci MT, Mancini A, Caputi M, Iaccarino I, Stoppelli MP.

Curr Drug Targets. 2011 Nov;12(12):1761-71. Review.


Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptor.

Alfano D, Votta G, Schulze A, Downward J, Caputi M, Stoppelli MP, Iaccarino I.

Mol Cell Biol. 2010 Apr;30(7):1838-51. doi: 10.1128/MCB.01442-09. Epub 2010 Feb 1.


Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis.

Carriero MV, Longanesi-Cattani I, Bifulco K, Maglio O, Lista L, Barbieri A, Votta G, Masucci MT, Arra C, Franco R, De Rosa M, Stoppelli MP, Pavone V.

Mol Cancer Ther. 2009 Sep;8(9):2708-17. doi: 10.1158/1535-7163.MCT-09-0174. Epub 2009 Aug 25.


Inhibition of migration and invasion of carcinoma cells by urokinase-derived antagonists of alphavbeta5 integrin activation.

Vocca I, Franco P, Alfano D, Votta G, Carriero MV, Estrada Y, Caputi M, Netti PA, Ossowski L, Stoppelli MP.

Int J Cancer. 2009 Jan 15;124(2):316-25. doi: 10.1002/ijc.23933.

Supplemental Content

Support Center